Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
2012 · PLoS ONE · 1,110 citations
https://doi.org/10.1371/journal.pone.0047559
J
John Granton
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
348
Papers
19.8K
Citations
68
h-index
166
i10-index
John Granton is an academic researcher from University Health Network. The author has contributed to research in topics: Pulmonary Hypertension Research and Treatments & Venous Thromboembolism Diagnosis and Management & Respiratory Support and Mechanisms. The author has an h-index of 68, co-authored 296 publications.
ORCID: 0000-0002-2639-5958Papers by this author
worksCell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis
2020 · EClinicalMedicine · 248 citations
https://doi.org/10.1016/j.eclinm.2019.100249
Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients
2021 · JAMA · 204 citations
https://doi.org/10.1001/jama.2021.13355
Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients
2021 · JAMA · 204 citations
https://doi.org/10.1001/jama.2021.13355
Strategies for lung- and diaphragm-protective ventilation in acute hypoxemic respiratory failure: a physiological trial
2022 · Critical Care · 113 citations
https://doi.org/10.1186/s13054-022-04123-9
Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors
2008 · Critical Care · 92 citations
https://doi.org/10.1186/cc6810
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat